News and Trends 12 Oct 2016 Italy has new €100M Factory for Biobased Butanediol …its greener alternative. Figure 1. Metabolic pathway that produces 1,4 butanediol. Instead of being derived from butane obtained in an oil refinery, this biobutanediol is made with an engineered strain… October 12, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2017 Swedish Biotech Team Steps Up in the Fight Against Type 2 Diabetes …kinase (AMPK) activator. AMPK restores energy balance during energy shortage, caused by exercise or caloric restriction, by suppressing consumption. Type 2 diabetes is characterized by metabolic and cardiovascular dysfunction, so… November 2, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2016 Drugging the Undruggable: New Acquisition to Boost GPCR Drugs …up to 30% of approved drugs and can hold the key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge… November 30, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Aug 2022 Five emerging biotech hubs in the Asia-Pacific region …Stemirna Therapeutics, developing mRNA drug platforms; and Innogen Pharmaceutical Technology, developing treatments for metabolic disorders like diabetes. Taiwan Taiwan sees the biotech industry as key to its national development, and… August 19, 2022 - 7 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Sector A – Z Index …Insect-borne diseases K Kidney disease L Lab automation Liver disease lung cancer M Macular degeneration medical cannabis Medtech Melanoma menopause mental health issues Metabolic disorders Microbiome mitochondria Monoclonal antibodies mpox… March 24, 2023 - 0 minutesmins - By Developer Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 The biggest private biotech investments in April 2024 …looks to usher in the next generation of obesity and metabolic disease therapies. Following Metsera on the list, in third place, was Obsidian Therapeutics, raising $160.5 million in series C… May 9, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat …is the first FDA-approved monoclonal antibody for any animal species and controls osteoarthritis pain with a once-monthly injection. Metabolic disease is also getting cat-specific options. Bexacat (bexagliflozin) became the first… August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates The plant and animal kingdom can help scientists study areas like extreme metabolic changes, obesity resistance, and muscle preservation, which can lead to the discovery of novel therapeutic targets and… October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 3 Sep 2025 Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand …key to reaching the tumor cells. We typically target a characteristic of a tumor, whether it’s an antigen, a receptor, or even metabolic pathways, the lock. What we call the… September 3, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2022 DNA synthesis: tackling the main bottleneck in biology research …research that could particularly be impacted are metabolic engineering, synthetic biology, genome editing and systems biology. “There is this quote from Nobel prize winner Richard Feynman I like coming back… June 13, 2022 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2019 French Biotech’s Plant Extract Cuts Blood Glucose in Prediabetic People …of Development and Medical Affairs at Valbiotis, told me. “This is a really interesting way to act on metabolic tissues.” Though lifestyle changes such as a balanced diet and regular… July 5, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Aug 2022 Clearance given to clinical trial with potential to change course of brain disease …functional and cognitive decline.” BV-101 is a novel, exclusively designed adeno-associated virus (AAV) gene therapy vector that simultaneously addresses the metabolic dysfunction of diseased neurons as well as contributes to… August 24, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email